Investment Banking

Appirio, Best Doctors Acquisitions Honored by M&A Atlas Awards

Two transactions for which William Blair served as sell-side advisor were recently recognized as Deal of the Year in their respective categories by Global M&A Network. Wipro's acquisition of Appirio was named Cross Border M&A Deal of the Year for large transactions, and Teladoc's acquisition of Best Doctors was named U.S. Corporate M&A Deal of the Year for middle-market transactions.

  • Appirio acquired by Wipro: In October 2016, William Blair advised Appirio, the Indianapolis-based provider of consulting services for, Workday, and other cloud applications, on its $500 million sale to India-based Wipro. The acquisition created one of the world's largest cloud transformation practices. Appirio, which had been a portfolio company of Fidelity, General Atlantic, GGV Capital, and Sequoia Capital, was attracted to William Blair's extensive knowledge of and experience in the IT services sector, particularly in the cloud services segment. William Blair's team possessed a unique market perspective given precedent transactions in both the Salesforce and Workday ecosystems.
  • Best Doctors acquired by Teladoc: In July 2017, William Blair advised Best Doctors, which connects individuals facing difficult medical treatment decisions with leading physicians to review the patients' diagnosis and treatment plans, on its $440 million sale to Teladoc, the first and largest telehealth platform in the United States. The acquisition of Best Doctors, which generates a significant portion of its revenue outside the United States, significantly expands Teladoc's geographic reach. The transaction represented William Blair's 39th healthcare technology transaction since January 2015.

The awards were announced at the ninth annual Americas M&A Atlas Awards, held November 2 in New York.

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news

Our Latest News

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit